Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Drug Resistance

Free Subscription Articles published in J Virol Retrieve available abstracts of 10 articles: HTML format

Single Articles

August 2025
1. MA Y, Ye C, Khalil AM, Mahmoud SH, et al
   A luminescent attenuated SARS-CoV-2 for the identification and validation of drug-resistant mutants.
   J Virol. 2025 Aug 7:e0082125. doi: 10.1128/jvi.00821.
   PubMed     Abstract available
   
   
   April 2025
2. HUANG Y, Liang G, Wang T, Ma Y, et al
   Research strategies of the N-peptide fusion inhibitor: a promising direction for discovering novel antivirals.
   J Virol. 2025 Apr 10:e0228924. doi: 10.1128/jvi.02289.
   PubMed     Abstract available
   
   
   March 2025
3. CHATTERJEE D, Niu L, Medjahed H, Ding S, et al
   A gp41 HR2 residue modulates the susceptibility of HIV-1 envelope glycoproteins to small molecule inhibitors targeting gp120.
   J Virol. 2025 Mar 27:e0226724. doi: 10.1128/jvi.02267.
   PubMed     Abstract available
   
   
   January 2025
4. FEDORCHENKO SV, Klimenko Z, Martynovich T, Solianyk I, et al
   Retreatment of patients with chronic hepatitis C, subtype 3a, and cirrhosis, who previously failed a regimen containing second-generation NS5A inhibitors with sofosbuvir + glecaprevir/pibrentasvir and ribavirin for 16-24 weeks.
   J Virol. 2025 Jan 22:e0184324. doi: 10.1128/jvi.01843.
   PubMed     Abstract available
   
   
   
5. COHEN P, Lambson BE, Mkhize NN, Moodley C, et al
   Resistance mutations that distinguish HIV-1 envelopes with discordant VRC01 phenotypes from multi-lineage infections in the HVTN703/HPTN081 trial: implications for cross-resistance.
   J Virol. 2025 Jan 16:e0173024. doi: 10.1128/jvi.01730.
   PubMed     Abstract available
   
   
   
6. ARORA P, Zhang L, Nehlmeier I, Kempf A, et al
   Host cell lectins ASGR1 and DC-SIGN jointly with TMEM106B confer ACE2 independence and imdevimab resistance to SARS-CoV-2 pseudovirus with spike mutation E484D.
   J Virol. 2025 Jan 10:e0123024. doi: 10.1128/jvi.01230.
   PubMed     Abstract available
   
   
   June 2024
7. LI S, Wei B, Xu L, Cong C, et al
   In vivo efficacy of phage cocktails against carbapenem resistance Acinetobacter baumannii in the rat pneumonia model.
   J Virol. 2024 Jun 12:e0046724. doi: 10.1128/jvi.00467.
   PubMed     Abstract available
   
   
   May 2024
8. DEKKER JG, Klaver B, Berkhout B, Das AT, et al
   Reverse transcription of HIV-1 2-LTR circle transcripts does frequently cause 3'-polypurine tract mutations implicated in dolutegravir resistance.
   J Virol. 2024 May 24:e0033524. doi: 10.1128/jvi.00335.
   PubMed    
   
   
   February 2024
9. HAN P, Lin W, Fan H, Tong Y, et al
   Characterization of phage evolution and phage resistance in drug-resistant Stenotrophomonas maltophilia.
   J Virol. 2024;98:e0124923.
   PubMed     Abstract available
   
   
   January 2024
10. TAN X, Chen K, Jiang Z, Liu Z, et al
    Evaluation of the impact of repeated intravenous phage doses on mammalian host-phage interactions.
    J Virol. 2024;98:e0135923.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.